Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,066
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/whole-foods-market-issues-allergy-alert-undeclared-egg-cabricharme-cheesePublished September 11, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 5,421–5,440 of 17,299 recalls

FDA Recall Terminated Historical recordClass II

Irbesartan Tablets USP, 300 mg a) 30 count (NDC 68180-412-06) and b) 90 count NDC# 68180-412-09) bottles, Rx only

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Irbesartan Tablets USP, 150 mg a) 30 count (NDC 68180-411-06) and b) 90 count (NDC 68180-411-09) bottles, Rx only

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Irbesartan Tablets USP, 75 mg a) 30 count (NDC 68180-410-06) and b) 90 count (NDC 68180-410-09) bottles, Rx only

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 count bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA NDC 43598-743-05

by Dr. Reddy's Laboratories, Inc.

Reason
Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, a) 30 count (NDC 43598-743-30), b) 90 count (NDC 43598-743-90) bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA

by Dr. Reddy's Laboratories, Inc.

Reason
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/80 mg, a) 30 count (NDC 43598-745-30), b) 90 count (NDC 43598-745-90), and c) 500 count (NDC 43598-745-05) bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA

by Dr. Reddy's Laboratories, Inc.

Reason
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/20 mg, a) 30 count (NDC 43598-744-30), b) 90 count (NDC 43598-744-90) bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA

by Dr. Reddy's Laboratories, Inc.

Reason
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, a) 90 count (NDC 43598-742-90) and b) 1000 count (NDC 43598-742-10) bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA, , packaged in bottles.

by Dr. Reddy's Laboratories, Inc.

Reason
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

ProSource Produce LLC

Product
Whole raw WHITE onions are imported from Chihuahua of MEXICO…
Reason
Salmonella Oranienburg.
Published
November 10, 2021
Distribution
Distributed in AL, AR, AZ, CA, CO, CT, F…

View recall →

FDA Recall United States Terminated Historical recordClass I

ProSource Produce LLC

Product
Whole raw YELLOW onions are imported from Chihuahua of MEXIC…
Reason
Salmonella Oranienburg.
Published
November 10, 2021
Distribution
Distributed in AL, AR, AZ, CA, CO, CT, F…

View recall →

FDA Recall United States Terminated Historical recordClass I

ProSource Produce LLC

Product
Whole raw RED onions are imported from Chihuahua of MEXICO.…
Reason
Salmonella Oranienburg.
Published
November 10, 2021
Distribution
Distributed in AL, AR, AZ, CA, CO, CT, F…

View recall →

FDA Recall United States Terminated Historical recordClass II

NSE Products, Inc.

Product
Pharmanex Kids Jungamals, Dietary Supplement 90 Chewable Tab…
Reason
Pharmanex Jungamals was found to have a missing fish allergen statement on the label due to fish gelatin as a sub-component of the Vitamin E ingredient.
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Pepsico Inc

Product
Starbucks Doubleshot Espresso, Espresso & Salted Caramel Cre…
Reason
An issue with adequate sealing of canned coffee products potentially lead to premature spoilage.
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Pepsico Inc

Product
Starbucks Doubleshot Espresso, Espresso & Light Cream, 6.5 F…
Reason
An issue with adequate sealing of canned coffee products potentially lead to premature spoilage.
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Pepsico Inc

Product
Starbucks Doubleshot Espresso, Espresso & Cream, 6.5 FL OZ U…
Reason
An issue with adequate sealing of canned coffee products potentially lead to premature spoilage.
Published
November 10, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-435-01.

by Lupin Pharmaceuticals Inc.

Reason
Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.
Published
November 3, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Rizatriptan Benzoate Orally Disintegrating Tablets 10mg, 18 Tablets (3 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-094-41

by MACLEODS PHARMA USA, INC

Reason
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Published
November 3, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-093-41

by MACLEODS PHARMA USA, INC

Reason
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Published
November 3, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Rizatriptan Benzoate Film Coated Tablets, 10 mg, packaged in a) 12 Tablets (2X6 Unit-Dose Tablets) Blister Packs, NDC 33342-088-45), b) 18 Tablets (3 x 6 Unit-Dose Tablets, NDC 33342-088-41) Rx only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536l Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA

by MACLEODS PHARMA USA, INC

Reason
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Published
November 3, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Afassco Pain Free Plus X-STRENGTH PAIN RELIEVER (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 Tablets/package, Packaged in 12,000 Packets/Case, PO# 19540, Mfg. for: Afassco Minden, NV 89423 (Shipping Label)

by Ultra Seal Corporation

Reason
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Published
November 3, 2021
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.